scholarly article | Q13442814 |
P2093 | author name string | Jing Li | |
Yuanyuan Li | |||
Xue Wang | |||
Ping Li | |||
Xingchen Zhou | |||
Lianwen Qi | |||
Su Jiang | |||
Ziwei Song | |||
Owais Ahmad | |||
P2860 | cites work | BLAST+: architecture and applications | Q21284368 |
Human gut microbiome viewed across age and geography | Q24602950 | ||
Functional analysis of active site residues of the fosfomycin resistance enzyme FosA from Pseudomonas aeruginosa | Q45291346 | ||
Rapid method for detection of minimal bactericidal concentration of antibiotics | Q46076525 | ||
Lack of development of new antimicrobial drugs: a potential serious threat to public health | Q48002635 | ||
[Adenovirus-mediated canine interferon-gamma expression and its antiviral activity against canine parvovirus] | Q64378712 | ||
[Concentrations of fosfomycin in serum and lung tissue] | Q71559604 | ||
The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs | Q81628423 | ||
Product of fosC, a gene from Pseudomonas syringae, mediates fosfomycin resistance by using ATP as cosubstrate | Q24676974 | ||
Structure and mechanism of the genomically encoded fosfomycin resistance protein, FosX, from Listeria monocytogenes | Q27645727 | ||
Structure and Function of the Genomically Encoded Fosfomycin Resistance Enzyme, FosB, from Staphylococcus aureus | Q27681408 | ||
The Amber biomolecular simulation programs | Q27860745 | ||
FosB, a cysteine-dependent fosfomycin resistance protein under the control of sigma(W), an extracytoplasmic-function sigma factor in Bacillus subtilis | Q28359895 | ||
Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa | Q28492484 | ||
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
Mechanisms of biofilm resistance to antimicrobial agents | Q29615293 | ||
Richness of human gut microbiome correlates with metabolic markers | Q29617365 | ||
Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis | Q33627296 | ||
Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in Staphylococcus aureus | Q33707109 | ||
The structure and function of drug pumps | Q34137973 | ||
Antibiotic resistance in the environment: a link to the clinic? | Q34138597 | ||
Mechanistic studies of FosB: a divalent-metal-dependent bacillithiol-S-transferase that mediates fosfomycin resistance in Staphylococcus aureus | Q34318798 | ||
Gut metagenome in European women with normal, impaired and diabetic glucose control | Q34347521 | ||
Potential of fecal microbiota for early-stage detection of colorectal cancer | Q34450065 | ||
Stability of gut enterotypes in Korean monozygotic twins and their association with biomarkers and diet | Q34648507 | ||
Gut microbiome development along the colorectal adenoma-carcinoma sequence | Q35574864 | ||
The gut microbiome of healthy Japanese and its microbial and functional uniqueness. | Q35948206 | ||
The comprehensive antibiotic resistance database. | Q36969864 | ||
Fosfomycin: an old, new friend? | Q37633415 | ||
The revival of fosfomycin | Q37938425 | ||
CTX-M-type β-lactamases: a successful story of antibiotic resistance | Q38089423 | ||
ARDB--Antibiotic Resistance Genes Database | Q38512415 | ||
The National Institutes of Health Human Microbiome Project | Q38878973 | ||
Resistance to macrolides and related antibiotics in Streptococcus pneumoniae | Q39652725 | ||
Identification of Novel Conjugative Plasmids with Multiple Copies of fosB that Confer High-Level Fosfomycin Resistance to Vancomycin-Resistant Enterococci | Q40071538 | ||
Characterization of Fosfomycin Resistance Gene, fosB, in Methicillin-Resistant Staphylococcus aureus Isolates | Q40687974 | ||
Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria | Q41010511 | ||
Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens | Q41078268 | ||
Plasmids of Diverse Inc Groups Disseminate the Fosfomycin Resistance Gene fosA3 among Escherichia coli Isolates from Pigs, Chickens, and Dairy Cows in Northeast China | Q42016011 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 200 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Frontiers in Microbiology | Q27723481 |
P1476 | title | Taxonomic Distribution of FosB in Human-Microbiota and Activity Comparison of Fosfomycin Resistance | |
P478 | volume | 10 |